Use of molecular topology in the selection of new cytostatic drugs

Journal of Molecular Structure: THEOCHEM

Volumn 504, Issue 1-3, 2000, Pages 241-248

  Galvez J ^a   Garcia Domenech R ^a   Gomez Lechon M J ^b   Castell, J V ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Antineoplastics; Antiproliferative effect; Molecular topology; Pharmacological distribution diagrams

Indexed keywords

8 AZAGUANINE; ANCITABINE; ANTIINFECTIVE AGENT; AZAURIDINE; BUSULFAN; CARBOQUONE; CARMUSTINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; DACARBAZINE; DIAZIQUONE; DOXORUBICIN; DROSTANOLONE PROPIONATE; ESMOLOL; FLUOROURACIL; LOMUSTINE; MERCAPTOPURINE; NAPROXEN; QUININE; TAXOL; TEGAFUR; TESTOLACTONE; TRIMETREXATE; UNINDEXED DRUG; URETHAN; URIDINE DERIVATIVE; VINBLASTINE; VINDESINE; ZORUBICIN;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN HEPG2; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG RESEARCH; HELA CELL; HUMAN; HUMAN CELL; MATHEMATICAL ANALYSIS;

EID: 0042296396     PISSN: 01661280     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-1280(00)00365-1     Document Type: Article

References (25)

1. Lahana R. Scientific American (Spanish edition). 254:1997;25.
2. Kier L.B., Hall L.H. Molecular Connectivity in Structure-Activity Analysis. 1986;Research Studies Press, Letchworth, England.
3. Muñoz C., de Julian-Ortiz J.V., Gimeno C., Catalán V., Gálvez J. Rev. Esp. Quimioter. 7:1994;279-280.
4. Gálvez J., García R., de Julian-Ortiz J.V., Soler R. J. Chem. Inf. Comput. Sci. 35:1995;272-284.
5. Antón-Fos G.M., Garcia-Domenech R., Perez-Gimenez F., Peris-Ribera J.E., García-March F.J., Salabert-Salvador M.T. Arzneim-Forsch/Drug Res. 44:1994;821-826.
6. Gálvez J., Garcia-Domenech R., de Gregorio-Alapont C., de Julián-Ortiz J.V., Salabert-Salvador M.T., Soler R. Advances in Molecular Similarity. vol. 1:1996;JAI Press. (pp. 267-280).
7. Garcia-Domenech R., de Gregorio-Alapont C., de Julián-Ortiz J.V., Gálvez J., Popa L. Bioorg. Med. Chem. Lett. 7:1997;567-572.
8. Gálvez J., Garcia R., de Julián-Ortiz J.V., Soler R. J. Chem. Inf. Comput. Sci. 34:1994;1198-1203.
9. Garcia-Domenech R., García-March F.J., Soler R., Gálvez J., Antón-Fos G.M., de Julian-Ortiz J.V. Quant. Struct.-Act. Relat. 15:1996;201-207.
10. Rios-Santamarina I., Gálvez J., Garcia-Domenech R., Cortijo J., Santamaria P., Morcillo E. Bioorg. Med. Chem. Lett. 8:1998;477-482.
11. Estrada E., Peña P., Garcia-Domenech R. J. Comput. Aid. Mol. Des. 12:1998;583-595.
12. Pastor L., Garcia-Domenech R., Wolski S., Garcia M.D., Gálvez J. Bioorg. Med. Chem. Lett. 8:1998;2577-2582.
13. Gozalbes R., Gálvez J., Moreno A., Garcia-Domenech R. J. Pharm. Pharmacol. 51:1999;111-117.
14. Gozalbes R., Gálvez J., Garcia-Domenech R., Derouin F. SAR and QSAR Env. Res. 10:1999;47-60.
15. Gálvez J., Gomez-Lechón M.J., Garcia-Domenech R., Castell J.V. Bioorg. Med. Chem. Lett. 6:1996;2301-2306.
16. Kier,W L.B., Murray J., Randic M., Hall L.H. J. Pharm. Sci. Soc. 97:1975;6609-6615.
17. Kier L.B., Hall L.H. Molecular Connectivity in Chemistry and Drug Research. 1976;Academic Press, London. (pp. 46-79).
18. Gálvez J., Garcia R., Salabert M.T., Soler R. J. Chem. Inf. Comput. Sci. 34:1994;520-525.
19. Collous T. Discriminant Analysis and Applications. 1973;Academic Press, New York.
20. Dixon W.J. Manual BMD Biomedical Computer Programs. 1982;University of California Press, Los Angeles.
21. Gálvez J., Garcia-Domenech R., de Gregorio-Alapont C., de Julián-Ortiz J.V., Popa L. J. Mol. Graph. 14:1996;272-276.
22. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Cancer Res. 47:1987;936-942.
23. Ponsoda X., Jover R., Nuñez C., Royo M., Castell J.V., Gómez-Lechón M.J. Toxic. In Vitro. 9:1995;959-996.
24. The Merck Index, 11th ed., Merck & Co Inc., Rahway, NJ, USA, 1989, 926pp.
25. Gálvez J. J. Mol. Struct. (Theochem). 429:1998;255-264.